PMC full text: | Published online 2024 Jul 10. doi: 10.2147/OPTH.S463653
|
Patient | Site of relapse (laterality) | Time to relapse (months) | Treatment after relapse |
---|---|---|---|
1 | Conjuntiva (R) | 55.9 | Observation |
2 | Conjuntiva (R, L) / cervical lymph nodes | 4.4/26.1 | R-TCOP |
6 | Pharynx and cervical lymph nodes | 14.3 | RT (pharynx) + R-CHOP |
7 | Tonsil and duodenum | 40.5 | R-bendamustine |
12 | Conjunctiva (L) | 54.6 | RT |
14 | Lung | 47.1 | Observation |
15 | Conjunctiva (R) | 19.3 | RT |
Abbreviations: R-TCOP, rituximab, pirarubicin, cyclophosphamide, vincristine, prednisolone; RT, radiation therapy; R-CHOP, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone; R-bendamustine, rituximab, bendamustine.